AssayIndex
Reports by quarter

Reports submitted in 2026-Q1 · page 17

Rule AX-R12 added. Dataset v2 schema published. Median purity for the quarter is 99.22 % area, n=806. Read the 2026-Q1 state-of-the-index report →

806 records21 pagesmedian on this page 99.36 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041620SelankFGPFGP-2511-D8133Janoshik2026-Q199.936.9193.8Buyer-sourced0PASS
AX-2026-041255SurvodutideWWBWWB-2510-R2141Janoshik2026-Q199.125.0496.9Buyer-sourced0PASS
AX-2026-042979SemaglutideMKMMKM-2508-R3717VendorInvestigate2026-Q199.145.4389.5Buyer-sourced1MARGINAL
AX-2026-042682Humanin (HNG)ERPERP-2601-P8786Janoshik2026-Q198.894.41—Buyer-sourced1MARGINAL
AX-2026-042552TirzepatideHJHJ-2508-P6487Janoshik2026-Q198.294.14100.5Laboratory-retained0PASS
AX-2026-042150ThymulinJEEPJEEP-2602-T8987Janoshik2026-Q199.814.75—Laboratory-retained0PASS
AX-2026-041993MOTS-cAMBAMB-2601-N5360Nordanalyt2026-Q199.704.3598.0Buyer-sourced0PASS
AX-2026-041578SemaglutideQSCQSC-2602-L7350Janoshik2026-Q199.933.79—Buyer-sourced0PASS
AX-2026-041544CJC-1295 (no DAC)QSCQSC-2508-D6762Janoshik2026-Q198.872.32—Buyer-sourced0PASS
AX-2026-041504SemaglutideQSCQSC-2509-Y6202Janoshik2026-Q199.634.76—Buyer-sourced0PASS
AX-2026-041483CJC-1295 with DACQSCQSC-2512-G5673Janoshik2026-Q198.852.74—Buyer-sourced0PASS
AX-2026-041467AOD-9604QYBQYB-2508-E5277Janoshik2026-Q199.513.77103.5Buyer-sourced0PASS
AX-2026-043508SemaglutideSIGSIG-2511-5925Janoshik2026-Q198.392.83—Buyer-sourced0PASS
AX-2026-042701GlucagonERPERP-2601-X8820Medutest2026-Q198.681.45—Buyer-sourced0PASS
AX-2026-042372SemaxHomopeptideHOMO-2601-D3090Janoshik2026-Q198.896.58—Buyer-sourced1MARGINAL
AX-2026-042360SemaxHomopeptideHOMO-2602-S3200Janoshik2026-Q199.698.98—Buyer-sourced0PASS
AX-2026-042288EpitalonTFCTFC-2511-E9934Medutest2026-Q199.936.34—Buyer-sourced0PASS
AX-2026-041986SS-31 (Elamipretide)AMBAMB-2512-D5166Medutest2026-Q199.475.8497.0Buyer-sourced0PASS
AX-2026-041937SemaxSinoPepSNP-2601-U4736Medutest2026-Q199.937.3099.5Supplier-supplied1MARGINAL
AX-2026-041624SelankFGPFGP-2511-D8133Janoshik2026-Q199.936.43105.5Buyer-sourced0PASS
AX-2026-041411GHRP-6QYBQYB-2602-X4422Kestrel2026-Q199.181.95104.1Buyer-sourced0PASS
AX-2026-041373IpamorelinWWBWWB-2601-C3477VendorInvestigate2026-Q199.326.1592.9Buyer-sourced0PASS
AX-2026-043639BPC-157PPGPPG-2511-C7828Janoshik2026-Q199.655.4596.6Buyer-sourced0PASS
AX-2026-042976MK-677 (Ibutamoren mesylate)MKMMKM-2509-T3949PeptideMeter2026-Q199.403.48—Buyer-sourced0FAIL
AX-2026-042697PEG-MGFERPERP-2509-K8683Kestrel2026-Q197.735.78—Buyer-sourced0PASS
AX-2026-042511Melanotan IIHomopeptideHOMO-2511-M5084Janoshik2026-Q199.424.11—Buyer-sourced0PASS
AX-2026-042207RetatrutideTFCTFC-2508-V8915Janoshik2026-Q199.204.21—Supplier-supplied0PASS
AX-2026-042196TB-500JEEPJEEP-2510-R9238Janoshik2026-Q199.934.60107.0Laboratory-retained2MARGINAL
AX-2026-041870RetatrutideSinoPepSNP-2603-G4042Janoshik2026-Q197.295.12—Buyer-sourced1MARGINAL
AX-2026-041712TirzepatideTFSTFS-{CAT}-1353VendorInvestigate2026-Q197.904.0788.8Buyer-sourced1MARGINAL
AX-2026-041456Humanin (HNG)QYBQYB-2512-A4980Janoshik2026-Q199.604.0198.3Buyer-sourced0PASS
AX-2026-041422BPC-157QYBQYB-2510-R4608Janoshik2026-Q199.936.37—Buyer-sourced0PASS
AX-2026-041347CJC-1295 with DACWWBWWB-2508-V3100Medutest2026-Q199.245.60103.5Buyer-sourced0PASS
AX-2026-043667TB-500PPGPPG-2512-D8068Medutest2026-Q199.414.67—Buyer-sourced1MARGINAL
AX-2026-043589SS-31 (Elamipretide)SIGSIG-2512-6369Kestrel2026-Q199.106.8797.8Buyer-sourced0PASS
AX-2026-043480IpamorelinBCHBCH-2510-P4971Nordanalyt2026-Q198.923.64103.9Buyer-sourced0FAIL
AX-2026-042554TirzepatideHJHJ-2508-P6487Medutest2026-Q199.114.26—Buyer-sourced0PASS
AX-2026-042430ARA-290HomopeptideHOMO-2602-K4395Janoshik2026-Q199.204.23104.8Buyer-sourced0PASS
AX-2026-042356SemaxHomopeptideHOMO-2602-S3200Janoshik2026-Q199.709.35—Buyer-sourced0PASS
AX-2026-042187TB-500JEEPJEEP-2510-R9238Janoshik2026-Q199.474.6194.9Buyer-sourced2MARGINAL